Furthermore, miRNA-770-5p reduces HER+ BC cell invasion and migration by suppressing the downstream signaling of PI3K and MAPK signaling cascades that cause resistance to anti-HER2 therapy [149]. The gene discussed is ERBB2; the disease is breast cancer.